Skip to main content
Signal8

Rolke James

SEC insider (Form 3/4/5 filer). CIK 0001693858. Chief Executive Officer at REVELATION BIOSCIENCES, INC. (REVB). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in SAN DIEGO, CA.

Companies Rolke James has filed insider reports for

  • REVELATION BIOSCIENCES, INC. (REVB): Director, Officer, Chief Executive Officer
Rolke James profile photo

Rolke James

CIK: 0001693858

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

REVELATION BIOSCIENCES, INC. logo
REVB

REVELATION BIOSCIENCES, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • REVELATION BIOSCIENCES, INC. logo
    REVB

    REVELATION BIOSCIENCES, INC.

    Aug 17, 2026
    Award
    Direct
    208.1K shares-
  • REVELATION BIOSCIENCES, INC. logo
    REVB

    REVELATION BIOSCIENCES, INC.

    Apr 30, 2026
    Tax Payment
    Direct
    10.1K shares at avg. $1.13$11K
  • REVELATION BIOSCIENCES, INC. logo
    REVB

    REVELATION BIOSCIENCES, INC.

    Feb 3, 2026
    Tax Payment
    Direct
    8.5K shares at avg. $1.86$16K
  • REVELATION BIOSCIENCES, INC. logo
    REVB

    REVELATION BIOSCIENCES, INC.

    Jan 8, 2026
    Award
    Direct
    532.8K shares at avg. $0.90$480K
  • REVELATION BIOSCIENCES, INC. logo
    REVB

    REVELATION BIOSCIENCES, INC.

    Oct 29, 2025
    Award
    Direct
    390.6K shares at avg. $1.28$500K
  • REVELATION BIOSCIENCES, INC. logo
    REVB

    REVELATION BIOSCIENCES, INC.

    Feb 11, 2025
    Award
    Direct
    30.1K shares at avg. $3.87$116K

1-6 of 6